Total Payments
$3,089
2024 Payments
$53.98
Companies
24
Transactions
176
Medicare Patients
4,826
Medicare Billing
$931,295
Payment Breakdown by Category
Food & Beverage$2,901 (93.9%)
Education$187.97 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,901 | 167 | 93.9% |
| Education | $187.97 | 9 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $476.44 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $444.90 | 30 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $352.18 | 21 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $310.16 | 21 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $221.09 | 14 | $0 (2021) |
| Amgen Inc. | $203.67 | 12 | $0 (2021) |
| Relypsa, Inc. | $179.17 | 12 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $163.92 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $144.37 | 3 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $113.37 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.98 | 4 | AKEBIA THERAPEUTICS INC ($49.22) |
| 2023 | $79.67 | 4 | AstraZeneca Pharmaceuticals LP ($39.36) |
| 2022 | $64.18 | 4 | Aurinia Pharma U.S., Inc. ($30.52) |
| 2021 | $525.99 | 32 | AstraZeneca Pharmaceuticals LP ($133.68) |
| 2020 | $571.24 | 37 | AstraZeneca Pharmaceuticals LP ($154.30) |
| 2019 | $835.63 | 46 | Otsuka America Pharmaceutical, Inc. ($205.63) |
| 2018 | $527.49 | 33 | Keryx Biopharmaceuticals, Inc. ($88.35) |
| 2017 | $431.13 | 16 | Otsuka America Pharmaceutical, Inc. ($125.00) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 12/04/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 11/14/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: KRYSTEXXA | ||||||
| 05/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 03/24/2023 | Baxter Healthcare | Gambro - Accute (Device) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Renal | ||||||
| 11/09/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/18/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEPHROLOGY | ||||||
| 06/29/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/08/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/06/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/30/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/16/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Hyperkalemia | ||||||
| 08/05/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Nephrology | ||||||
| 08/03/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardio-renal | ||||||
| 07/22/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/19/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.29 | General |
| Category: NEPHROLOGY | ||||||
| 07/12/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Nephrology | ||||||
| 06/22/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Nephrology | ||||||
| 06/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,027 | 2,220 | $649,511 | $178,757 |
| 2022 | 16 | 1,039 | 1,966 | $651,487 | $184,897 |
| 2021 | 14 | 1,156 | 2,570 | $832,167 | $245,250 |
| 2020 | 18 | 1,604 | 3,512 | $1.3M | $322,391 |
Total Patients
4,826
Total Services
10,268
Medicare Billing
$931,295
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 33 | 238 | $226,100 | $61,463 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 191 | 603 | $95,877 | $35,223 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 302 | 390 | $90,870 | $21,535 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 118 | 135 | $43,462 | $12,940 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $23,520 | $6,926 | 29.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 43 | 197 | $29,550 | $6,887 | 23.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 40 | 192 | $22,080 | $6,601 | 29.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 74 | $16,724 | $6,554 | 39.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 23 | $21,850 | $5,010 | 22.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 51 | 72 | $26,280 | $3,783 | 14.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 17 | 50 | $18,250 | $3,163 | 17.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 17 | 18 | $17,100 | $2,689 | 15.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 27 | 77 | $6,160 | $2,241 | 36.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 54 | $5,184 | $1,943 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,224 | $1,346 | 31.9% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 30 | 38 | $2,280 | $453.56 | 19.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 45 | 274 | $260,300 | $71,659 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 205 | 644 | $102,396 | $33,322 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 331 | $77,123 | $22,372 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 81 | 81 | $39,690 | $13,161 | 33.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 76 | 133 | $30,058 | $10,143 | 33.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 72 | $32,256 | $9,677 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 60 | 69 | $22,149 | $6,630 | 29.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 19 | $18,050 | $4,260 | 23.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 42 | 63 | $22,995 | $3,398 | 14.8% |
About Dr. Benjamin Studdard, M.D
Dr. Benjamin Studdard, M.D is a Nephrology healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588928980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Studdard, M.D has received a total of $3,089 in payments from pharmaceutical and medical device companies, with $53.98 received in 2024. These payments were reported across 176 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,901).
As a Medicare-enrolled provider, Studdard has provided services to 4,826 Medicare beneficiaries, totaling 10,268 services with total Medicare billing of $931,295. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Murfreesboro, TN
- Active Since 06/29/2012
- Last Updated 09/26/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588928980
Products in Payments
- LOKELMA (Drug) $405.88
- Velphoro (Drug) $299.30
- JYNARQUE (Drug) $268.42
- AURYXIA (Drug) $235.18
- Veltassa (Drug) $210.65
- SAMSCA (Drug) $197.13
- Auryxia (Drug) $167.72
- Parsabiv (Biological) $160.45
- RAYALDEE (Drug) $134.60
- ACTHAR (Biological) $113.37
- SOLIRIS (Drug) $109.87
- ZORTRESS (Drug) $109.23
- Rayaldee (Drug) $86.49
- LUPKYNIS (Drug) $76.39
- KRYSTEXXA (Biological) $51.99
- Vafseo (Drug) $49.22
- Ozempic (Drug) $45.45
- Parsabiv (Drug) $43.22
- KRYSTEXXA (Drug) $40.75
- Ultomiris (Drug) $39.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Murfreesboro
Christie Green, Md, MD
Nephrology — Payments: $10,433
Nephrology $10,433
Jyotheen Karam, M.d, M.D
Nephrology — Payments: $3,594
Nephrology $3,594
Christin Giordano Mcauliffe, Md, MD
Nephrology — Payments: $512.03
Nephrology $512.03
Ann Herron, Md, MD
Nephrology — Payments: $332.43
Nephrology $332.43
Dr. Taylor Chaney, Do, DO
Nephrology
Nephrology